Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Alzheimer's Disease”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Not applicableLooking for participantsNCT07485387
What this trial is testing

Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort

Who this might be right for
Mild Cognitive Impairment (MCI)Dementia Alzheimer TypeChronic Pain+1 more
Korea University 180
Testing effectiveness (Phase 2)Looking for participantsNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Not applicableStudy completedNCT04860414
What this trial is testing

Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.

Who this might be right for
Cognitive Disorders
Centre Hospitalier Universitaire Dijon 45
Not applicableStudy completedNCT04573985
What this trial is testing

Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder

Who this might be right for
Family Caregiver of Patient With Alzheimer Disease
Centre Hospitalier Universitaire de Nice 40
Testing effectiveness (Phase 2)Study completedNCT05074498
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TrueBinding, Inc. 154
Large-scale testing (Phase 3)Study completedNCT00478205
What this trial is testing

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 1,467
Large-scale testing (Phase 3)Ended earlyNCT00857649
What this trial is testing

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 369
Not applicableWithdrawnNCT04327778
What this trial is testing

Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes

Who this might be right for
Alzheimer DiseaseMajor Neurocognitive Disorder
Centre Hospitalier Universitaire de Nice
Not applicableUnknownNCT03672279
What this trial is testing

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Who this might be right for
Dementia AlzheimersMild Cognitive ImpairmentCognition Disorders+1 more
University Hospital, Basel, Switzerland 100
Not applicableStudy completedNCT04992195
What this trial is testing

Impact of COVID-19 Vaccines on Cerebrovascular Health

Who this might be right for
StrokeStroke, AcuteStroke, Ischemic+7 more
Chinese University of Hong Kong 415
Testing effectiveness (Phase 2)Study completedNCT03765762
What this trial is testing

Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

Who this might be right for
Severe Alzheimer Disease
Alkahest, Inc. 26
Large-scale testing (Phase 3)Study completedNCT02035982
What this trial is testing

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Sunnybrook Health Sciences Centre 40
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT03430869
What this trial is testing

Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)

Who this might be right for
Major Depressive Disorder
Chang Gung Memorial Hospital 59
Not applicableUnknownNCT02681822
What this trial is testing

Multi-center Imaging Genetics Studies in China

Who this might be right for
Alzheimer DiseaseSchizophreniaMajor Depressive Disorders
Tianjin Medical University General Hospital 10,000
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Not applicableNot Yet RecruitingNCT07631247
What this trial is testing

IPath for CP Pilot

Who this might be right for
Depression - Major Depressive Disorder
Dartmouth-Hitchcock Medical Center 15
Large-scale testing (Phase 3)Study completedNCT00216593
What this trial is testing

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

Who this might be right for
DementiaAlzheimer Disease
Janssen Pharmaceutica N.V., Belgium 415
Next Page